LPPL
RVMD icon

Loftus Peak Pty Ltd’s Revolution Medicines RVMD Stock Holding History

Loftus Peak Pty Ltd’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.5M Sell
94,803
-1,291
-1% -$256K 2.49% 18
2026
Q2 		$18M Buy
+96,094
New +$14M 2.45% 17

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
First Citizens Bank & Trust
First Citizens Bank & Trust Raleigh, North Carolina $6.73B AUM 18.92% 1-Year Est. Return

Loftus Peak Pty Ltd's RVMD Position: Q3 2026 in Review

Loftus Peak Pty Ltd reduced its Revolution Medicines (RVMD) stake by 1.3% in Q3 2026, selling an estimated $256K and leaving 94,803 shares worth $19.5M. The position accounts for 2.49% of the portfolio, ranked #18.

Loftus Peak Pty Ltd first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Loftus Peak Pty Ltd held 94,803 shares of Revolution Medicines worth $19.5M as of Q3 2026.
  • Loftus Peak Pty Ltd sold 1,291 Revolution Medicines shares in Q3 2026, an estimated $256K.
  • Revolution Medicines made up 2.49% of Loftus Peak Pty Ltd's portfolio in Q3 2026, its #18 holding.
  • Loftus Peak Pty Ltd first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Loftus Peak Pty Ltd's 13F filing for Q3 2026, filed 15 Oct 2026.